Literature DB >> 27807619

Ophthalmic findings in myotonic dystrophy type 2: a case series.

Hannah M Kersten1,2, Helen V Danesh-Meyer1, Richard H Roxburgh3,4.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27807619     DOI: 10.1007/s00415-016-8325-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  14 in total

1.  Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery.

Authors:  S M S Ghazi-Nouri; P G Tranos; G S Rubin; Z C Adams; D G Charteris
Journal:  Br J Ophthalmol       Date:  2006-01-18       Impact factor: 4.638

2.  Optical coherence tomography.

Authors:  D Huang; E A Swanson; C P Lin; J S Schuman; W G Stinson; W Chang; M R Hee; T Flotte; K Gregory; C A Puliafito
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

Review 3.  The myotonic dystrophies: diagnosis and management.

Authors:  Chris Turner; David Hilton-Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-02-22       Impact factor: 10.154

4.  Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.

Authors:  C L Liquori; K Ricker; M L Moseley; J F Jacobsen; W Kress; S L Naylor; J W Day; L P Ranum
Journal:  Science       Date:  2001-08-03       Impact factor: 47.728

Review 5.  Myotonic dystrophy type 2.

Authors:  J Finsterer
Journal:  Eur J Neurol       Date:  2002-09       Impact factor: 6.089

6.  Retinal changes in myotonic dystrophy. Clinical and follow-up evaluation.

Authors:  Y Kimizuka; M Kiyosawa; M Tamai; S Takase
Journal:  Retina       Date:  1993       Impact factor: 4.256

7.  Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study.

Authors:  Samantha Fraser-Bell; Magdalena Guzowski; Elena Rochtchina; Jie Jin Wang; Paul Mitchell
Journal:  Ophthalmology       Date:  2003-01       Impact factor: 12.079

8.  Ocular Findings of Myotonic Dystrophy Type 1 in the Korean Population.

Authors:  Se Hyun Choi; Hee Kyung Yang; Jeong-Min Hwang; Kyung Seok Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-27       Impact factor: 3.117

9.  Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1.

Authors:  Hannah M Kersten; Richard H Roxburgh; Nicholas Child; Philip J Polkinghorne; Chris Frampton; Helen V Danesh-Meyer
Journal:  J Neurol       Date:  2013-10-17       Impact factor: 4.849

10.  Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.

Authors:  Tiina Suominen; Linda L Bachinski; Satu Auvinen; Peter Hackman; Keith A Baggerly; Corrado Angelini; Leena Peltonen; Ralf Krahe; Bjarne Udd
Journal:  Eur J Hum Genet       Date:  2011-03-02       Impact factor: 4.246

View more
  2 in total

1.  The New Zealand Neuromuscular Disease Patient Registry; Five Years and a Thousand Patients.

Authors:  Miriam J Rodrigues; Gina L O'Grady; Graeme Hammond-Tooke; Alexa Kidd; Donald O Love; Ronelle K Baker; Richard H Roxburgh
Journal:  J Neuromuscul Dis       Date:  2017

2.  Fundus flavimaculatus-like in myotonic dystrophy: a case report.

Authors:  Eric Kirkegaard-Biosca; Mònica Berges-Marti; Brahim Azarfane; Esther Cilveti; Laura Distefano; Jose García-Arumí
Journal:  BMC Ophthalmol       Date:  2021-05-29       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.